According to Yomiuri News Paper, I found a interesting topic about obesity. From this topic I leaned that animal also could become obesity.
Not a remedy for overweight people, FDA warns
Thursday, Jan. 11, 2007 -- Recognizing that overeating isn't limited to beings with two legs, the U.S. Food and Drug Administration (FDA) has approved the first prescription drug to manage obesity in DOGS.
Pfizer Animal Health (NYSE: PFE) announced that SLENTROL™ (dirlotapide), the first and only FDA-approved veterinary medication for the management of canine (relating to dogs) obesity, is now available by prescription in the United States. Pfizer is the obesity agent for dogs. The FDA cited surveys showing that up to 30 percent of U.S. dogs are overweight and about 5 percent are obese (more than 20 percent above ideal weight).
Overweight pets, like people, are at higher risk of health problems ranging from cardiovascular conditions and joint problems to diabetes, the FDA said.
To discourage use of the medication by people, Stentrol's label will warn that the drug is not intended for human use, should be kept away from children, and may cause adverse reactions in people, including abdominal pain (stomach), diarrhea, headache, nausea and vomiting.
"Slentrol, First Medication to Combat Canine Obesity, Now Available by Prescription." Pfizer News. June 12,2007.Pfizer.26June2007. http://mediaroom.pfizer.com/portal/site/pfizer/index.jsp?ndmViewId=news_view&ndmConfigId=1006533&newsId=20070612005727&newsLang=en
Not a remedy for overweight people, FDA warns
Thursday, Jan. 11, 2007 -- Recognizing that overeating isn't limited to beings with two legs, the U.S. Food and Drug Administration (FDA) has approved the first prescription drug to manage obesity in DOGS.
Pfizer Animal Health (NYSE: PFE) announced that SLENTROL™ (dirlotapide), the first and only FDA-approved veterinary medication for the management of canine (relating to dogs) obesity, is now available by prescription in the United States. Pfizer is the obesity agent for dogs. The FDA cited surveys showing that up to 30 percent of U.S. dogs are overweight and about 5 percent are obese (more than 20 percent above ideal weight).
Overweight pets, like people, are at higher risk of health problems ranging from cardiovascular conditions and joint problems to diabetes, the FDA said.
To discourage use of the medication by people, Stentrol's label will warn that the drug is not intended for human use, should be kept away from children, and may cause adverse reactions in people, including abdominal pain (stomach), diarrhea, headache, nausea and vomiting.
"Slentrol, First Medication to Combat Canine Obesity, Now Available by Prescription." Pfizer News. June 12,2007.Pfizer.26June2007. http://mediaroom.pfizer.com/portal/site/pfizer/index.jsp?ndmViewId=news_view&ndmConfigId=1006533&newsId=20070612005727&newsLang=en
Engin ummæli:
Skrifa ummæli